Sunshine Biopharma, Inc. ( SBFMW) - Key Metrics
SBFMW Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $6.78 | -$1.15 | -$0.67 | -$0.67 |
| 2026Q1 | $16.49 | -$2.54 | -$4.22 | -$4.23 |
| 2025Q4 | $20.63 | -$5.15 | -$3.89 | -$2.03 |
| 2025Q3 | $20.24 | -$1.90 | -$1.56 | -$1.64 |
| 2025Q2 | $418.59 | -$78.77 | -$56.64 | -$81.12 |
SBFMW Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.46 |
| 2026Q1 | 0% | -1.04 |
| 2025Q4 | 0% | -0.67 |
| 2025Q3 | 0% | -1.96 |
| 2025Q2 | 0% | -0.05 |
SBFMW
Price: $0.03
52 week price:
Earnings Per Share: -2.21 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 126146